The treatment has shown positive results in a 6-month-old patient, with improvements in health and weight, and has been presented at a major medical conference.
Company Description
KJ's Gene Therapy is focused on developing personalized CRISPR gene-editing therapies for ultra-rare genetic mutations, providing rapid treatment solutions for patients with life-threatening conditions.